Biomimetic sensor technologies focusing on dopamine and nitric oxide neurotransmitter biosensing have emerged as pivotal tools in biomedical research and healthcare. This chapter provides a comprehensive overview of current advancements, challenges, future perspectives, and societal impacts of these sensors. Neurotransmitter biosensing is critical for understanding complex biological processes and disease mechanisms. Dopamine, a key neurotransmitter involved in reward pathways and motor control, and nitric oxide, a versatile signaling molecule influencing cardiovascular and neurological functions, are central to neurological and cardiovascular health. Biomimetic sensors utilize advanced nanomaterials and innovative electrode designs to enhance sensitivity and selectivity in detecting these molecules. Optical and microfluidic sensor technologies further enable non-invasive, real-time monitoring in biological samples, facilitating precise quantification and insights into neurotransmitter dynamics. Applications of dopamine biosensing span neuroscience research, offering insights into Parkinson’s disease, addiction, and cognitive function. Nitric oxide biosensors contribute to understanding neurodegenerative disorders, stroke, and cardiovascular diseases by monitoring vascular tone and immune response. However, challenges such as biocompatibility, stability in biological environments, and regulatory hurdles must be addressed to realize the full potential of these technologies. Emerging technologies including wearable sensors and nanomaterial-based platforms hold promise for enhancing sensor performance, portability, and integration capabilities. These advancements are poised to revolutionize healthcare diagnostics, personalized medicine, and environmental monitoring by enabling early disease detection, optimizing treatment outcomes, and monitoring environmental pollutants in real-time. Biomimetic sensor technologies for dopamine and nitric oxide biosensing represent a transformative approach in biomedical research and healthcare, promising significant advancements in understanding neurotransmitter dynamics and their impact on health and disease.

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Future Perspectives

  • Deepa Suhag

摘要

Biomimetic sensor technologies focusing on dopamine and nitric oxide neurotransmitter biosensing have emerged as pivotal tools in biomedical research and healthcare. This chapter provides a comprehensive overview of current advancements, challenges, future perspectives, and societal impacts of these sensors. Neurotransmitter biosensing is critical for understanding complex biological processes and disease mechanisms. Dopamine, a key neurotransmitter involved in reward pathways and motor control, and nitric oxide, a versatile signaling molecule influencing cardiovascular and neurological functions, are central to neurological and cardiovascular health. Biomimetic sensors utilize advanced nanomaterials and innovative electrode designs to enhance sensitivity and selectivity in detecting these molecules. Optical and microfluidic sensor technologies further enable non-invasive, real-time monitoring in biological samples, facilitating precise quantification and insights into neurotransmitter dynamics. Applications of dopamine biosensing span neuroscience research, offering insights into Parkinson’s disease, addiction, and cognitive function. Nitric oxide biosensors contribute to understanding neurodegenerative disorders, stroke, and cardiovascular diseases by monitoring vascular tone and immune response. However, challenges such as biocompatibility, stability in biological environments, and regulatory hurdles must be addressed to realize the full potential of these technologies. Emerging technologies including wearable sensors and nanomaterial-based platforms hold promise for enhancing sensor performance, portability, and integration capabilities. These advancements are poised to revolutionize healthcare diagnostics, personalized medicine, and environmental monitoring by enabling early disease detection, optimizing treatment outcomes, and monitoring environmental pollutants in real-time. Biomimetic sensor technologies for dopamine and nitric oxide biosensing represent a transformative approach in biomedical research and healthcare, promising significant advancements in understanding neurotransmitter dynamics and their impact on health and disease.